Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blue

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Surgical Education|September 25, 2016
The Effect of Patient Education on the Perceptions of Resident Participation in Surgical CareJason W Kempenich, Ross E Willis, Robert J Blue, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 7, 2013
Dysphagia in the setting of left ventricular assist device hemolysisRobert J Mentz, Kelly Schlendorf, Adrian F Hernandez, et al.
American Heart Journal|May 27, 2019
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) studyHaider J Warraich, Larry A Allen, Laura J Blue, et al.
The Annals of Thoracic Surgery|August 28, 2007
Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patientsJacob N Schroder, Mani A Daneshmand, Nestor R Villamizar, et al.
The Annals of Thoracic Surgery|October 1, 2011
Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantationValentino Piacentino, Constantine D Troupes, Asvin M Ganapathi, et al.
The American Journal of Cardiology|June 21, 2015
Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous FlowMani A Daneshmand, Arun Krishnamoorthy, Marc D Samsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
The Eurasian heartland: a continental perspective on Y-chromosome diversityR S Wells, N Yuldasheva, R Ruzibakiev, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Blood Advances|June 12, 2023
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myelomaDae Hyun Lee, Abhishek Kumar, Turab Mohammed, et al.
Blood Advances|October 19, 2023
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapyLauren C Peres, Laura B Oswald, Christen M Dillard, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Surgical Education|September 25, 2016
The Effect of Patient Education on the Perceptions of Resident Participation in Surgical CareJason W Kempenich, Ross E Willis, Robert J Blue, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 7, 2013
Dysphagia in the setting of left ventricular assist device hemolysisRobert J Mentz, Kelly Schlendorf, Adrian F Hernandez, et al.
American Heart Journal|May 27, 2019
Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) studyHaider J Warraich, Larry A Allen, Laura J Blue, et al.
The Annals of Thoracic Surgery|August 28, 2007
Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patientsJacob N Schroder, Mani A Daneshmand, Nestor R Villamizar, et al.
The Annals of Thoracic Surgery|October 1, 2011
Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantationValentino Piacentino, Constantine D Troupes, Asvin M Ganapathi, et al.
The American Journal of Cardiology|June 21, 2015
Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous FlowMani A Daneshmand, Arun Krishnamoorthy, Marc D Samsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
The Eurasian heartland: a continental perspective on Y-chromosome diversityR S Wells, N Yuldasheva, R Ruzibakiev, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Blood Advances|June 12, 2023
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myelomaDae Hyun Lee, Abhishek Kumar, Turab Mohammed, et al.
Blood Advances|October 19, 2023
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapyLauren C Peres, Laura B Oswald, Christen M Dillard, et al.
Pageof 6